Source:http://linkedlifedata.com/resource/pubmed/id/16196281
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-10-3
|
pubmed:abstractText |
The specific anti-tumor immune response induced by mouse bone marrow dendritic cells (DCs) transfected with recombinant adenovirus carrying mutant k-ras genes was investigated. DCs were generated from mouse bone marrow in the presence of rmGM-CSF (3.3 ng/mL) and rmIL-4 (1.3 ng/mL) and detected by FACS, and then transfected with the recombinant adenovirus encoding mutant k-ras gene. The efficacy of transfection and T cell stimulating activity of DCs were detected. CTL activity of the mice vaccinated with DCs was observed. The results showed that DCs had dendritic veiled morphology. BmDCs highly expressed B7-1 (80%), B7-2 (77%), MHC II (70%), CD11c (65%), CD40 (70%) and CD54 (96%) with FACS, and no significant difference in the expression was observed before and after the transfection (P > 0.05). The DCs transfected by mutant k-ras gene could significantly stimulate lymphocytes proliferation as compared with those transfected by Ad-c or non-modified DCs (P < 0.05). DC vaccine transfected by mutant k-ras gene could induce CTL activity against Lewis lung cancer, but not against B16. The specific cytotoxicity against Lewis lung cancer in Ad-k-ras/12-transduced DC group was significantly higher than those in the control, vector and non-transfected DCs groups (P < 0.05). It was concluded that special antitumor response could be induced by DCs transfected with recombinant adenovirus carrying mutant k-ras genes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1672-0733
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
378-81
|
pubmed:meshHeading |
pubmed-meshheading:16196281-Adenoviridae,
pubmed-meshheading:16196281-Animals,
pubmed-meshheading:16196281-Cancer Vaccines,
pubmed-meshheading:16196281-Dendritic Cells,
pubmed-meshheading:16196281-Genes, ras,
pubmed-meshheading:16196281-Genetic Vectors,
pubmed-meshheading:16196281-Lung Neoplasms,
pubmed-meshheading:16196281-Mice,
pubmed-meshheading:16196281-Mice, Inbred C57BL,
pubmed-meshheading:16196281-Mutation,
pubmed-meshheading:16196281-Recombination, Genetic,
pubmed-meshheading:16196281-Transfection,
pubmed-meshheading:16196281-Tumor Cells, Cultured,
pubmed-meshheading:16196281-Vaccines, DNA
|
pubmed:year |
2005
|
pubmed:articleTitle |
In vitro anti-tumor immune response induced by dendritic cells transfected with recombinant adenovirus carrying mutant K-ras genes.
|
pubmed:affiliation |
Department of Thoracic Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|